nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Myalgia—Sorafenib—thyroid cancer	0.00251	0.00251	CcSEcCtD
Cefpodoxime—Vaginal inflammation—Epirubicin—thyroid cancer	0.00249	0.00249	CcSEcCtD
Cefpodoxime—Nocturia—Doxorubicin—thyroid cancer	0.00249	0.00249	CcSEcCtD
Cefpodoxime—Dry mouth—Sorafenib—thyroid cancer	0.00245	0.00245	CcSEcCtD
Cefpodoxime—Hyperkalaemia—Epirubicin—thyroid cancer	0.00245	0.00245	CcSEcCtD
Cefpodoxime—Eructation—Epirubicin—thyroid cancer	0.00245	0.00245	CcSEcCtD
Cefpodoxime—Diarrhoea—Vandetanib—thyroid cancer	0.00244	0.00244	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Sorafenib—thyroid cancer	0.00241	0.00241	CcSEcCtD
Cefpodoxime—Candida infection—Epirubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Cefpodoxime—Skin exfoliation—Epirubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Cefpodoxime—Shock—Sorafenib—thyroid cancer	0.00237	0.00237	CcSEcCtD
Cefpodoxime—Dizziness—Vandetanib—thyroid cancer	0.00236	0.00236	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Sorafenib—thyroid cancer	0.00236	0.00236	CcSEcCtD
Cefpodoxime—Vaginal infection—Epirubicin—thyroid cancer	0.00235	0.00235	CcSEcCtD
Cefpodoxime—Aplastic anaemia—Epirubicin—thyroid cancer	0.00234	0.00234	CcSEcCtD
Cefpodoxime—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00231	0.00231	CcSEcCtD
Cefpodoxime—Anorexia—Sorafenib—thyroid cancer	0.00229	0.00229	CcSEcCtD
Cefpodoxime—Vomiting—Vandetanib—thyroid cancer	0.00227	0.00227	CcSEcCtD
Cefpodoxime—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
Cefpodoxime—Eructation—Doxorubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
Cefpodoxime—Rash maculo-papular—Epirubicin—thyroid cancer	0.00226	0.00226	CcSEcCtD
Cefpodoxime—Mouth ulceration—Epirubicin—thyroid cancer	0.00225	0.00225	CcSEcCtD
Cefpodoxime—Rash—Vandetanib—thyroid cancer	0.00225	0.00225	CcSEcCtD
Cefpodoxime—Dermatitis—Vandetanib—thyroid cancer	0.00225	0.00225	CcSEcCtD
Cefpodoxime—Headache—Vandetanib—thyroid cancer	0.00223	0.00223	CcSEcCtD
Cefpodoxime—Candida infection—Doxorubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Cefpodoxime—Skin exfoliation—Doxorubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00219	0.00219	CcSEcCtD
Cefpodoxime—Vaginal infection—Doxorubicin—thyroid cancer	0.00218	0.00218	CcSEcCtD
Cefpodoxime—Aplastic anaemia—Doxorubicin—thyroid cancer	0.00216	0.00216	CcSEcCtD
Cefpodoxime—Mental disability—Epirubicin—thyroid cancer	0.00216	0.00216	CcSEcCtD
Cefpodoxime—Dyspnoea—Sorafenib—thyroid cancer	0.00214	0.00214	CcSEcCtD
Cefpodoxime—Nausea—Vandetanib—thyroid cancer	0.00212	0.00212	CcSEcCtD
Cefpodoxime—Dyspepsia—Sorafenib—thyroid cancer	0.00212	0.00212	CcSEcCtD
Cefpodoxime—Rash maculo-papular—Doxorubicin—thyroid cancer	0.0021	0.0021	CcSEcCtD
Cefpodoxime—Decreased appetite—Sorafenib—thyroid cancer	0.00209	0.00209	CcSEcCtD
Cefpodoxime—Mouth ulceration—Doxorubicin—thyroid cancer	0.00208	0.00208	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00208	0.00208	CcSEcCtD
Cefpodoxime—Fatigue—Sorafenib—thyroid cancer	0.00207	0.00207	CcSEcCtD
Cefpodoxime—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00207	0.00207	CcSEcCtD
Cefpodoxime—Constipation—Sorafenib—thyroid cancer	0.00206	0.00206	CcSEcCtD
Cefpodoxime—Pain—Sorafenib—thyroid cancer	0.00206	0.00206	CcSEcCtD
Cefpodoxime—Mental disability—Doxorubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Cefpodoxime—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00199	0.00199	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00197	0.00197	CcSEcCtD
Cefpodoxime—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00192	0.00192	CcSEcCtD
Cefpodoxime—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00191	0.00191	CcSEcCtD
Cefpodoxime—Urticaria—Sorafenib—thyroid cancer	0.00191	0.00191	CcSEcCtD
Cefpodoxime—Abdominal pain—Sorafenib—thyroid cancer	0.0019	0.0019	CcSEcCtD
Cefpodoxime—Body temperature increased—Sorafenib—thyroid cancer	0.0019	0.0019	CcSEcCtD
Cefpodoxime—Renal impairment—Epirubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Cefpodoxime—Dermatitis bullous—Epirubicin—thyroid cancer	0.00189	0.00189	CcSEcCtD
Cefpodoxime—Hypoglycaemia—Epirubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Cefpodoxime—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Cefpodoxime—Hyponatraemia—Epirubicin—thyroid cancer	0.00182	0.00182	CcSEcCtD
Cefpodoxime—Migraine—Epirubicin—thyroid cancer	0.00178	0.00178	CcSEcCtD
Cefpodoxime—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00177	0.00177	CcSEcCtD
Cefpodoxime—Hypersensitivity—Sorafenib—thyroid cancer	0.00177	0.00177	CcSEcCtD
Cefpodoxime—Renal impairment—Doxorubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Cefpodoxime—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Cefpodoxime—Face oedema—Epirubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Cefpodoxime—Asthenia—Sorafenib—thyroid cancer	0.00173	0.00173	CcSEcCtD
Cefpodoxime—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Cefpodoxime—Pruritus—Sorafenib—thyroid cancer	0.0017	0.0017	CcSEcCtD
Cefpodoxime—Dehydration—Epirubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Cefpodoxime—Hyponatraemia—Doxorubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Cefpodoxime—Dry skin—Epirubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Cefpodoxime—Migraine—Doxorubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Cefpodoxime—Diarrhoea—Sorafenib—thyroid cancer	0.00165	0.00165	CcSEcCtD
Cefpodoxime—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Cefpodoxime—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Cefpodoxime—Face oedema—Doxorubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Cefpodoxime—Gastritis—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Cefpodoxime—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Cefpodoxime—Dizziness—Sorafenib—thyroid cancer	0.00159	0.00159	CcSEcCtD
Cefpodoxime—Abdominal distension—Epirubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Cefpodoxime—Asthma—Epirubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Cefpodoxime—Dehydration—Doxorubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Cefpodoxime—Eosinophilia—Epirubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Cefpodoxime—Dry skin—Doxorubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Cefpodoxime—Vomiting—Sorafenib—thyroid cancer	0.00153	0.00153	CcSEcCtD
Cefpodoxime—Rash—Sorafenib—thyroid cancer	0.00152	0.00152	CcSEcCtD
Cefpodoxime—Dermatitis—Sorafenib—thyroid cancer	0.00152	0.00152	CcSEcCtD
Cefpodoxime—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Cefpodoxime—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Cefpodoxime—Headache—Sorafenib—thyroid cancer	0.00151	0.00151	CcSEcCtD
Cefpodoxime—Bronchitis—Epirubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Cefpodoxime—Pancytopenia—Epirubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Cefpodoxime—Gastritis—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Cefpodoxime—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Cefpodoxime—Neutropenia—Epirubicin—thyroid cancer	0.00146	0.00146	CcSEcCtD
Cefpodoxime—Dysuria—Epirubicin—thyroid cancer	0.00146	0.00146	CcSEcCtD
Cefpodoxime—Abdominal distension—Doxorubicin—thyroid cancer	0.00146	0.00146	CcSEcCtD
Cefpodoxime—Asthma—Doxorubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Cefpodoxime—Pollakiuria—Epirubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Eosinophilia—Doxorubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Cefpodoxime—Nausea—Sorafenib—thyroid cancer	0.00143	0.00143	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Cefpodoxime—Weight increased—Epirubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Epirubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Cefpodoxime—Pneumonia—Epirubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Cefpodoxime—Bronchitis—Doxorubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Cefpodoxime—Pancytopenia—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Renal failure—Epirubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Stomatitis—Epirubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Neutropenia—Doxorubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Cefpodoxime—Dysuria—Doxorubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Cefpodoxime—Pollakiuria—Doxorubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Cefpodoxime—Haematuria—Epirubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Weight increased—Doxorubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Epistaxis—Epirubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Cefpodoxime—Sinusitis—Epirubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Cefpodoxime—Agranulocytosis—Epirubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Cefpodoxime—Pneumonia—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Cefpodoxime—Renal failure—Doxorubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Cefpodoxime—Haemoglobin—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Cefpodoxime—Stomatitis—Doxorubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Cefpodoxime—Rhinitis—Epirubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Cefpodoxime—Haemorrhage—Epirubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Cefpodoxime—Oedema peripheral—Epirubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Cefpodoxime—Haematuria—Doxorubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Cefpodoxime—Epistaxis—Doxorubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Cefpodoxime—Sinusitis—Doxorubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Cefpodoxime—Agranulocytosis—Doxorubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Cefpodoxime—Erythema multiforme—Epirubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Cefpodoxime—Tinnitus—Epirubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Cefpodoxime—Haemoglobin—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Cefpodoxime—Rhinitis—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Cefpodoxime—Haemorrhage—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Cefpodoxime—Oedema peripheral—Doxorubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Cefpodoxime—Chills—Epirubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Cefpodoxime—Alopecia—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Cefpodoxime—Erythema multiforme—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Cefpodoxime—Tinnitus—Doxorubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Cefpodoxime—Flatulence—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Cefpodoxime—Tension—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Cefpodoxime—Dysgeusia—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Cefpodoxime—Nervousness—Epirubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Cefpodoxime—Back pain—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Cefpodoxime—Chills—Doxorubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Cefpodoxime—Alopecia—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Cefpodoxime—Anaemia—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Cefpodoxime—Agitation—Epirubicin—thyroid cancer	0.001	0.001	CcSEcCtD
Cefpodoxime—Flatulence—Doxorubicin—thyroid cancer	0.000993	0.000993	CcSEcCtD
Cefpodoxime—Tension—Doxorubicin—thyroid cancer	0.000989	0.000989	CcSEcCtD
Cefpodoxime—Dysgeusia—Doxorubicin—thyroid cancer	0.000987	0.000987	CcSEcCtD
Cefpodoxime—Malaise—Epirubicin—thyroid cancer	0.000982	0.000982	CcSEcCtD
Cefpodoxime—Nervousness—Doxorubicin—thyroid cancer	0.000979	0.000979	CcSEcCtD
Cefpodoxime—Vertigo—Epirubicin—thyroid cancer	0.000979	0.000979	CcSEcCtD
Cefpodoxime—Syncope—Epirubicin—thyroid cancer	0.000977	0.000977	CcSEcCtD
Cefpodoxime—Leukopenia—Epirubicin—thyroid cancer	0.000975	0.000975	CcSEcCtD
Cefpodoxime—Back pain—Doxorubicin—thyroid cancer	0.000975	0.000975	CcSEcCtD
Cefpodoxime—Palpitations—Epirubicin—thyroid cancer	0.000963	0.000963	CcSEcCtD
Cefpodoxime—Loss of consciousness—Epirubicin—thyroid cancer	0.000957	0.000957	CcSEcCtD
Cefpodoxime—Cough—Epirubicin—thyroid cancer	0.000951	0.000951	CcSEcCtD
Cefpodoxime—Convulsion—Epirubicin—thyroid cancer	0.000944	0.000944	CcSEcCtD
Cefpodoxime—Hypertension—Epirubicin—thyroid cancer	0.00094	0.00094	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000935	0.000935	CcSEcCtD
Cefpodoxime—Anaemia—Doxorubicin—thyroid cancer	0.000932	0.000932	CcSEcCtD
Cefpodoxime—Chest pain—Epirubicin—thyroid cancer	0.000927	0.000927	CcSEcCtD
Cefpodoxime—Myalgia—Epirubicin—thyroid cancer	0.000927	0.000927	CcSEcCtD
Cefpodoxime—Agitation—Doxorubicin—thyroid cancer	0.000926	0.000926	CcSEcCtD
Cefpodoxime—Anxiety—Epirubicin—thyroid cancer	0.000924	0.000924	CcSEcCtD
Cefpodoxime—Discomfort—Epirubicin—thyroid cancer	0.000916	0.000916	CcSEcCtD
Cefpodoxime—Malaise—Doxorubicin—thyroid cancer	0.000909	0.000909	CcSEcCtD
Cefpodoxime—Dry mouth—Epirubicin—thyroid cancer	0.000907	0.000907	CcSEcCtD
Cefpodoxime—Vertigo—Doxorubicin—thyroid cancer	0.000906	0.000906	CcSEcCtD
Cefpodoxime—Syncope—Doxorubicin—thyroid cancer	0.000904	0.000904	CcSEcCtD
Cefpodoxime—Leukopenia—Doxorubicin—thyroid cancer	0.000902	0.000902	CcSEcCtD
Cefpodoxime—Confusional state—Epirubicin—thyroid cancer	0.000896	0.000896	CcSEcCtD
Cefpodoxime—Palpitations—Doxorubicin—thyroid cancer	0.000891	0.000891	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Epirubicin—thyroid cancer	0.000889	0.000889	CcSEcCtD
Cefpodoxime—Loss of consciousness—Doxorubicin—thyroid cancer	0.000886	0.000886	CcSEcCtD
Cefpodoxime—Cough—Doxorubicin—thyroid cancer	0.000879	0.000879	CcSEcCtD
Cefpodoxime—Shock—Epirubicin—thyroid cancer	0.000875	0.000875	CcSEcCtD
Cefpodoxime—Convulsion—Doxorubicin—thyroid cancer	0.000873	0.000873	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Epirubicin—thyroid cancer	0.00087	0.00087	CcSEcCtD
Cefpodoxime—Hypertension—Doxorubicin—thyroid cancer	0.00087	0.00087	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Epirubicin—thyroid cancer	0.000859	0.000859	CcSEcCtD
Cefpodoxime—Myalgia—Doxorubicin—thyroid cancer	0.000858	0.000858	CcSEcCtD
Cefpodoxime—Chest pain—Doxorubicin—thyroid cancer	0.000858	0.000858	CcSEcCtD
Cefpodoxime—Anxiety—Doxorubicin—thyroid cancer	0.000855	0.000855	CcSEcCtD
Cefpodoxime—Discomfort—Doxorubicin—thyroid cancer	0.000848	0.000848	CcSEcCtD
Cefpodoxime—Anorexia—Epirubicin—thyroid cancer	0.000847	0.000847	CcSEcCtD
Cefpodoxime—Dry mouth—Doxorubicin—thyroid cancer	0.000839	0.000839	CcSEcCtD
Cefpodoxime—Hypotension—Epirubicin—thyroid cancer	0.000831	0.000831	CcSEcCtD
Cefpodoxime—Confusional state—Doxorubicin—thyroid cancer	0.000829	0.000829	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000823	0.000823	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00081	0.00081	CcSEcCtD
Cefpodoxime—Shock—Doxorubicin—thyroid cancer	0.000809	0.000809	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000805	0.000805	CcSEcCtD
Cefpodoxime—Insomnia—Epirubicin—thyroid cancer	0.000804	0.000804	CcSEcCtD
Cefpodoxime—Paraesthesia—Epirubicin—thyroid cancer	0.000798	0.000798	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000795	0.000795	CcSEcCtD
Cefpodoxime—Dyspnoea—Epirubicin—thyroid cancer	0.000793	0.000793	CcSEcCtD
Cefpodoxime—Somnolence—Epirubicin—thyroid cancer	0.00079	0.00079	CcSEcCtD
Cefpodoxime—Anorexia—Doxorubicin—thyroid cancer	0.000784	0.000784	CcSEcCtD
Cefpodoxime—Dyspepsia—Epirubicin—thyroid cancer	0.000783	0.000783	CcSEcCtD
Cefpodoxime—Decreased appetite—Epirubicin—thyroid cancer	0.000773	0.000773	CcSEcCtD
Cefpodoxime—Hypotension—Doxorubicin—thyroid cancer	0.000769	0.000769	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000767	0.000767	CcSEcCtD
Cefpodoxime—Fatigue—Epirubicin—thyroid cancer	0.000766	0.000766	CcSEcCtD
Cefpodoxime—Pain—Epirubicin—thyroid cancer	0.00076	0.00076	CcSEcCtD
Cefpodoxime—Constipation—Epirubicin—thyroid cancer	0.00076	0.00076	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000749	0.000749	CcSEcCtD
Cefpodoxime—Insomnia—Doxorubicin—thyroid cancer	0.000744	0.000744	CcSEcCtD
Cefpodoxime—Paraesthesia—Doxorubicin—thyroid cancer	0.000739	0.000739	CcSEcCtD
Cefpodoxime—Dyspnoea—Doxorubicin—thyroid cancer	0.000733	0.000733	CcSEcCtD
Cefpodoxime—Feeling abnormal—Epirubicin—thyroid cancer	0.000733	0.000733	CcSEcCtD
Cefpodoxime—Somnolence—Doxorubicin—thyroid cancer	0.000731	0.000731	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000727	0.000727	CcSEcCtD
Cefpodoxime—Dyspepsia—Doxorubicin—thyroid cancer	0.000724	0.000724	CcSEcCtD
Cefpodoxime—Decreased appetite—Doxorubicin—thyroid cancer	0.000715	0.000715	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00071	0.00071	CcSEcCtD
Cefpodoxime—Fatigue—Doxorubicin—thyroid cancer	0.000709	0.000709	CcSEcCtD
Cefpodoxime—Urticaria—Epirubicin—thyroid cancer	0.000706	0.000706	CcSEcCtD
Cefpodoxime—Pain—Doxorubicin—thyroid cancer	0.000703	0.000703	CcSEcCtD
Cefpodoxime—Constipation—Doxorubicin—thyroid cancer	0.000703	0.000703	CcSEcCtD
Cefpodoxime—Body temperature increased—Epirubicin—thyroid cancer	0.000703	0.000703	CcSEcCtD
Cefpodoxime—Abdominal pain—Epirubicin—thyroid cancer	0.000703	0.000703	CcSEcCtD
Cefpodoxime—Feeling abnormal—Doxorubicin—thyroid cancer	0.000678	0.000678	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000673	0.000673	CcSEcCtD
Cefpodoxime—Hypersensitivity—Epirubicin—thyroid cancer	0.000655	0.000655	CcSEcCtD
Cefpodoxime—Urticaria—Doxorubicin—thyroid cancer	0.000653	0.000653	CcSEcCtD
Cefpodoxime—Abdominal pain—Doxorubicin—thyroid cancer	0.00065	0.00065	CcSEcCtD
Cefpodoxime—Body temperature increased—Doxorubicin—thyroid cancer	0.00065	0.00065	CcSEcCtD
Cefpodoxime—Asthenia—Epirubicin—thyroid cancer	0.000638	0.000638	CcSEcCtD
Cefpodoxime—Pruritus—Epirubicin—thyroid cancer	0.000629	0.000629	CcSEcCtD
Cefpodoxime—Diarrhoea—Epirubicin—thyroid cancer	0.000608	0.000608	CcSEcCtD
Cefpodoxime—Hypersensitivity—Doxorubicin—thyroid cancer	0.000606	0.000606	CcSEcCtD
Cefpodoxime—Asthenia—Doxorubicin—thyroid cancer	0.00059	0.00059	CcSEcCtD
Cefpodoxime—Dizziness—Epirubicin—thyroid cancer	0.000588	0.000588	CcSEcCtD
Cefpodoxime—Pruritus—Doxorubicin—thyroid cancer	0.000582	0.000582	CcSEcCtD
Cefpodoxime—Vomiting—Epirubicin—thyroid cancer	0.000565	0.000565	CcSEcCtD
Cefpodoxime—Diarrhoea—Doxorubicin—thyroid cancer	0.000563	0.000563	CcSEcCtD
Cefpodoxime—Rash—Epirubicin—thyroid cancer	0.000561	0.000561	CcSEcCtD
Cefpodoxime—Dermatitis—Epirubicin—thyroid cancer	0.00056	0.00056	CcSEcCtD
Cefpodoxime—Headache—Epirubicin—thyroid cancer	0.000557	0.000557	CcSEcCtD
Cefpodoxime—Dizziness—Doxorubicin—thyroid cancer	0.000544	0.000544	CcSEcCtD
Cefpodoxime—Nausea—Epirubicin—thyroid cancer	0.000528	0.000528	CcSEcCtD
Cefpodoxime—Vomiting—Doxorubicin—thyroid cancer	0.000523	0.000523	CcSEcCtD
Cefpodoxime—Rash—Doxorubicin—thyroid cancer	0.000519	0.000519	CcSEcCtD
Cefpodoxime—Dermatitis—Doxorubicin—thyroid cancer	0.000518	0.000518	CcSEcCtD
Cefpodoxime—Headache—Doxorubicin—thyroid cancer	0.000515	0.000515	CcSEcCtD
Cefpodoxime—Nausea—Doxorubicin—thyroid cancer	0.000489	0.000489	CcSEcCtD
